Publications
Found 3 results
Filters: Author is Q. Pei [Clear All Filters]
“Cinnamon effectively inhibits the activity of leukemia stem cells”, vol. 15, p. -, 2016.
, “Cinnamon effectively inhibits the activity of leukemia stem cells”, vol. 15, p. -, 2016.
, “Serum lipid abnormalities are not associated with apoB 3' VNTR polymorphism in nephrotic children”, vol. 12, pp. 765-774, 2013.
, Bairaktari E, Hatzidimou K, Tzallas C, Vini M, et al. (2000). Estimation of LDL cholesterol based on the Friedewald formula and on apo B levels. Clin. Biochem. 33: 549-555.
http://dx.doi.org/10.1016/S0009-9120(00)00162-4
Batanian JR, Ledbetter DH and Fenwick RG (1998). A simple VNTR-PCR method for detecting maternal cell contamination in prenatal diagnosis. Genet. Test. 2: 347-350.
http://dx.doi.org/10.1089/gte.1998.2.347
PMid:10464615
Boerwinkle E, Xiong WJ, Fourest E and Chan L (1989). Rapid typing of tandemly repeated hypervariable loci by the polymerase chain reaction: application to the apolipoprotein B 3' hypervariable region. Proc. Natl. Acad. Sci. U. S. A. 86: 212-216.
http://dx.doi.org/10.1073/pnas.86.1.212
PMid:2911570 PMCid:286434
Choong ML, Koay ES, Khaw MC and Aw TC (1999). Apolipoprotein B 5'-Ins/Del and 3'-VNTR polymorphisms in Chinese, malay and Indian singaporeans. Hum. Hered. 49: 31-40.
http://dx.doi.org/10.1159/000022837
PMid:9858855
Cohen SL, Cramp DG, Lewis AD and Tickner TR (1980). The mechanism of hyperlipidaemia in nephrotic syndrome--role of low albumin and the LCAT reaction. Clin. Chim. Acta 104: 393-400.
http://dx.doi.org/10.1016/0009-8981(80)90398-8
Deka R, Chakraborty R, DeCroo S, Rothhammer F, et al. (1992). Characteristics of polymorphism at a VNTR locus 3' to the apolipoprotein B gene in five human populations. Am. J. Hum. Genet. 51: 1325-1333.
PMid:1463014 PMCid:1682919
Destro-Bisol G, Presciuttini S, d'Aloja E, Dobosz M, et al. (1994). Genetic variation at the ApoB 3'HVR, D2S44, and D7S21 loci in the Ewondo Ethnic Group of Cameroon. Am. J. Hum. Genet. 55: 168-174.
PMid:7912886 PMCid:1918238
Dixit M, Srivastava A, Choudhuri G and Mittal B (2008). Higher alleles of apolipoprotein B Gene 3' VNTR: risk for gallstone disease. Ind. J. Clin. Biochem. 23: 123-129.
http://dx.doi.org/10.1007/s12291-008-0029-z
PMid:23105737 PMCid:3453088
Dixit VM and Hettiaratchi ES (1979). The mechanism of hyperlipidaemia in the nephrotic syndrome. Med. Hypotheses 5: 1327-1331.
http://dx.doi.org/10.1016/0306-9877(79)90102-6
Friedl W, Ludwig EH, Paulweber B, Sandhofer F, et al. (1990). Hypervariability in a minisatellite 3' of the apolipoprotein B gene in patients with coronary heart disease compared with normal controls. J. Lipid Res. 31: 659-665.
PMid:2351870
Gipson DS, Massengill SF, Yao L, Nagaraj S, et al. (2009). Management of childhood onset nephrotic syndrome. Pediatrics 124: 747-757.
http://dx.doi.org/10.1542/peds.2008-1559
PMid:19651590
Gong WK, Cheung W and Yap HK (2000). Minimal change nephrotic syndrome - a complex genetic disorder. Ann. Acad. Med. Singapore 29: 351-356.
PMid:10976389
Gordillo R and Spitzer A (2009). The nephrotic syndrome. Pediatr. Rev. 30: 94-104.
http://dx.doi.org/10.1542/pir.30-3-94
PMid:19255123
Hansen PS, Gerdes LU, Klausen IC, Gregersen N, et al. (1993). Polymorphisms in the apolipoprotein B-100 gene contributes to normal variation in plasma lipids in 464 Danish men born in 1948. Hum. Genet. 91: 45-50.
http://dx.doi.org/10.1007/BF00230221
PMid:8095917
Hokken-Koelega AC, Hackeng WH, Stijnen T, Wit JM, et al. (1990). Twenty-four-hour plasma growth hormone (GH) profiles, urinary GH excretion, and plasma insulin-like growth factor-I and -II levels in prepubertal children with chronic renal insufficiency and severe growth retardation. J. Clin. Endocrinol. Metab 71: 688-695.
http://dx.doi.org/10.1210/jcem-71-3-688
PMid:2394775
Hu P, Lu L, Hu B and Du PF (2009a). Characteristics of lipid metabolism under different urinary protein excretion in children with primary nephrotic syndrome. Scand. J. Clin. Lab. Invest. 69: 680-686.
http://dx.doi.org/10.3109/00365510902980751
PMid:19468931
Hu P, Qin YH, Jing CX, Lei FY, et al. (2009b). Association of polymorphisms at restriction enzyme recognition sites of apolipoprotein B and E gene with dyslipidemia in children undergoing primary nephrotic syndrome. Mol. Biol. Rep. 36: 1015-1021.
http://dx.doi.org/10.1007/s11033-008-9275-7
PMid:18512131
Hu P, Qin YH, Jing CX, Lu L, et al. (2009c). Effect of apolipoprotein B polymorphism on body mass index, serum protein and lipid profiles in children of Guangxi, China. Ann. Hum. Biol. 36: 411-420.
http://dx.doi.org/10.1080/03014460902882475
PMid:19449275
Hu P, Qin YH, Hu B and Lu L (2010). Hypervariability in a minisatellite 3' of the apolipoprotein B gene: allelic distribution and influence on lipid profiles in Han Children from central China. Clin. Chim. Acta 411: 2092-2096.
http://dx.doi.org/10.1016/j.cca.2010.09.010
PMid:20837003
Hu P, Wang J, Hu B, Lu L, et al. (2012). Dyslipidemia acts as a close link between cardiovascular risk and renal progression in nephrotic children. Asian Biomed. 6: 151-157.
Huang LS and Breslow JL (1987). A unique AT-rich hypervariable minisatellite 3' to the ApoB gene defines a high information restriction fragment length polymorphism. J. Biol. Chem. 262: 8952-8955.
PMid:2885324
Khrunin A, Verbenko D, Nikitina K and Limborska S (2007). Regional differences in the genetic variability of Finno- Ugric speaking Komi populations. Am. J. Hum. Biol. 19: 741-750.
http://dx.doi.org/10.1002/ajhb.20620
PMid:17691096
Lechner BL, Bockenhauer D, Iragorri S, Kennedy TL, et al. (2004). The risk of cardiovascular disease in adults who have had childhood nephrotic syndrome. Pediatr. Nephrol. 19: 744-748.
http://dx.doi.org/10.1007/s00467-004-1460-x
PMid:15085419
Mitsnefes MM (2008). Cardiovascular complications of pediatric chronic kidney disease. Pediatr. Nephrol. 23: 27-39.
http://dx.doi.org/10.1007/s00467-006-0359-0
PMid:17120060 PMCid:2100430
Noguera NI, Tallano CE, Bragos IM and Milani AC (2000). Modified salting-out method for DNA isolation from newborn cord blood nucleated cells. J. Clin. Lab. Anal. 14: 280-283.
http://dx.doi.org/10.1002/1098-2825(20001212)14:6<280::AID-JCLA6>3.0.CO;2-0
Pan JP, Chiang AN, Chou CY, Chan WL, et al. (1998). Polymorphisms of the apolipoprotein B 3' variable number of tandem repeats region associated with coronary artery disease in Taiwanese. J. Formos. Med. Assoc. 97: 233-238.
PMid:9585673
Pontrelli L, Sidiropoulos KG and Adeli K (2004). Translational control of apolipoprotein B mRNA: regulation via cis elements in the 5' and 3' untranslated regions. Biochemistry 43: 6734-6744.
http://dx.doi.org/10.1021/bi049887s
PMid:15157107
Rantala M, Rantala TT, Savolainen MJ, Friedlander Y, et al. (2000). Apolipoprotein B gene polymorphisms and serum lipids: meta-analysis of the role of genetic variation in responsiveness to diet. Am. J. Clin. Nutr. 71: 713-724.
PMid:10702164
Rebhi L, Omezzine A, Kchok K, Belkahla R, et al. (2008). 5' ins/del and 3' VNTR polymorphisms in the apolipoprotein B gene in relation to lipids and coronary artery disease. Clin. Chem. Lab. Med. 46: 329-334.
http://dx.doi.org/10.1515/CCLM.2008.067
PMid:18254714
Ruf RG, Wolf MT, Hennies HC, Lucke B, et al. (2003). A gene locus for steroid-resistant nephrotic syndrome with deafness maps to chromosome 14q24.2. J. Am. Soc. Nephrol. 14: 1519-1522.
http://dx.doi.org/10.1097/01.ASN.0000066141.55735.8D
PMid:12761252
Ruixing Y, Guangqin C, Yong W, Weixiong L, et al. (2007). Effect of the 3'APOB-VNTR polymorphism on the lipid profiles in the Guangxi Hei Yi Zhuang and Han populations. BMC Med. Genet. 8: 45.
http://dx.doi.org/10.1186/1471-2350-8-45
PMid:17640344 PMCid:1939985
Sajantila A, Lukka M and Syvanen AC (1999). Experimentally observed germline mutations at human micro- and minisatellite loci. Eur. J. Hum. Genet. 7: 263-266.
http://dx.doi.org/10.1038/sj.ejhg.5200257
PMid:10196715
Segrest JP, Jones MK, De Loof H and Dashti N (2001). Structure of apolipoprotein B-100 in low density lipoproteins. J. Lipid Res. 42: 1346-1367.
PMid:11518754
Soares-Vieira JA, Billerbeck AE, Iwamura ES, Cardoso L, et al. (2000). Post-mortem forensic identity testing: application of PCR to the identification of fire victim. Sao Paulo Med. J. 118: 75-77.
http://dx.doi.org/10.1590/S1516-31802000000300005
PMid:10810332
Tovar AR, Murguia F, Cruz C, Hernandez-Pando R, et al. (2002). A soy protein diet alters hepatic lipid metabolism gene expression and reduces serum lipids and renal fibrogenic cytokines in rats with chronic nephrotic syndrome. J. Nutr. 132: 2562-2569.
PMid:12221209
Verbenko DA, Pogoda TV, Spitsyn VA, Mikulich AI, et al. (2003). Apolipoprotein B 3'-VNTR polymorphism in Eastern European populations. Eur. J. Hum. Genet. 11: 444-451.
http://dx.doi.org/10.1038/sj.ejhg.5200986
PMid:12774037
Wiecek A, Kokot F, Strzelczyk P, Witkowicz J, et al. (1993). Relationship between renal biopsy histopathology and profile of changes in serum protein, lipids and proteinuria in patients with nephrotic syndrome due to chronic glomerulonephritis. Pol. Arch. Med. Wewn. 90: 426-432.
PMid:8146046
Yasuda N and Kimura M (1968). A gene-counting method of maximum likelihood for estimating gene frequencies in ABO and ABO-like systems. Ann. Hum. Genet. 31: 409-420.
http://dx.doi.org/10.1111/j.1469-1809.1968.tb00574.x
PMid:5673164